I doubt there is much in the bodget yet for Axon Sports Emmjay. The opportunity is certainly there but have a feeling its a 12-18 mth timeframe they are looking at to get it firing.
In the meantime the high dollar is killing their traditional clinical trial business margins. Nice to be cash flow positive but revenue was terrible.Doesn't augur well for nxt quarters receipts.Desperately need new initiatives like the recently announced schizophrenia win.
Tough grind for a while longer I suspect although at some stage the market will start to factor in the upside.
Cheers
I doubt there is much in the bodget yet for Axon Sports Emmjay....
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.060(4.74%) |
Mkt cap ! $205.7M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.24 | $1.19 | $101.5K | 84.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4400 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 16000 | 1 |
View Market Depth
| Last trade - 15.59pm 29/07/2024 (20 minute delay) ? |
| CGS (ASX) Chart |